This module focuses on psychopharmacological treatments during the early phases of psychosis. Leading experts in the field will discuss conceptual and practical guidelines for the pharmacological management of both the prodromal and first episode phase of the illness. Students will learn about the rationale and principles for developing a personalized pharmacological intervention plan. The module incorporates the latest research findings including emerging pharmacological therapies. Specific topics include:
- Introduction to psychopharmacology
- The pharmacological basis of early intervention in psychosis
- Pharmacological treatment of children and adolescents with psychosis
- Treatment resistance: causes and management
- Clinical strategies to maximise adherence
- Predictors of response to pharmacological treatment in psychosis
- On the being treated by early intervention services: the service user’s perspective.
Paolo Fusar-Poli (module leader), Philip McGuire, Robin Murray, James MacCabe, Matthew Taylor, Paola Dazzan, Eduardo Iacoponi, Oliver Howes, Andrea Cipriani, Dan Hayes.
Mondays & Tuesdays; 10am-12pm & 2-4pm. Please note, the study times detailed here are typical and give you a good indication of what to expect. However, they may change if the course modules change.
Module assessment - more information
Students are required to submit one 2,500 word coursework essay that counts for 25% of the overall module mark.
Students are required to sit one 2-hour written examination in March that counts for 75% of the overall module mark.